Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
25+ Key Opinion Leaders (KOLs) were contacted for insights on Glucagon-like Peptide-1 (GLP-1) Agonists incorporation in the evolving treatment landscape, patient reliance on conventional therapies, patient therapy switching acceptability, drug uptake, along with challenges related to accessibility
In recent years, GLP-1RAs have become well-established therapies in T2DM
I also like the knob, versus buttons
Benyoucef, S., Surinya, K
Pharmaceutics (2024) 3
US$ 29.48
US$ 22.08
US$ 27.35
US$ 28.68
US$ 20.30
US$ 21.23
US$ 22.70
US$ 22.16
US$ 29.56
